Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson’s disease model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson’s disease model

Published:2019-02 Issue: Volume:1704 Page:47-58
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Lee Yujeong,Cho Jung-Hyun,Lee Seulah,Lee Wonjong,Chang Seung-Cheol,Chung Hae Young,Moon Hyung Ryong,Lee Jaewon

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference53 articles.

1. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders;Agarwal;Biochem. Biophys. Res. Commun.,2017

2. PPAR dual agonists: are they opening Pandora's Box?;Balakumar;Pharmacol. Res.,2007

3. Peroxisome proliferator-activated receptors: a critical review on endogenous pathways for ligand generation;Bishop-Bailey;Prostaglandins Other Lipid Mediat.,2003

4. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases;Bordet;Biochem. Soc. Trans.,2006

5. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease;Borlongan;Brain Res.,1995

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer’s Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy;International Journal of Molecular Sciences;2024-06-28

2. Retinoid X Receptor as a Novel Drug Target to Treat Neurological Disorders Associated with α- Synucleinopathies;2024-06-10

3. Omega-3 fatty acids' supplementation in Parkinson's disease: A systematic review of randomized controlled trials;Clinical Nutrition Open Science;2024-06

4. What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson’s Disease?;International Journal of Molecular Sciences;2024-01-29

5. PPAR agonists for the treatment of neuroinflammatory diseases;Trends in Pharmacological Sciences;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3